Novel Polyphenol Compounds for Mitochondrial Dysfunction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current polyphenolic natural products, such as catechins, have limitations including low potency and undesirable pharmacodynamic or pharmacokinetic profiles, necessitating the development of new polyphenol compounds for effective therapeutic applications.
Innovation Solution
Development of novel polyphenol compounds, including derivatives represented by formulas (I), (II), and (III), and their pharmaceutically acceptable salts, which can be used in pharmaceutical compositions to treat diseases related to mitochondrial dysfunction and electron transfer chain modification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If polyphenolic natural products such as catechins are used, then biological activities and health benefits are achieved, but potency and pharmacodynamic/pharmacokinetic profiles are insufficient
Solution Approach 1:
The patent modifies the chemical structure of polyphenolic compounds by changing parameters such as introducing heteroatoms (nitrogen, oxygen), modifying substituent groups, and adjusting molecular weight to enhance potency and pharmacokinetic properties while maintaining biological activity
Solution Approach 2:
The patent creates composite polyphenolic compounds by combining multiple functional groups and structural motifs (e.g., flavonoid cores with modified substituents, heterocyclic rings) to achieve synergistic effects that improve both potency and therapeutic efficacy
Data Source
AI summary
The present application discloses derivatives of polyphenols, pharmaceutically acceptable salts, stereoisomers or tautomers thereof, and processes for preparation thereof. The compounds and compositions described herein can be used in therapy.